| Category | Adjuvants |
| Molecular Formula | C54H106N3O17P |
| Molecular Weight | 1100.40 |
| Appearance | Powder |
| Storage | Store at -20°C |
3A-MPLA
Monophosphoryl lipid A (MPLA) is an analog of the lipid A moiety. It is regarded as a detoxified derivative of the lipopolysaccharide (LPS). MPLA is a natural agonist for the toll-like receptor-4 (TLR4). MPLA is a safe prophylactic agent and has immunotherapeutic applications. It induces tumor necrosis factor and interleukin (IL)-1β, however not as efficient as lipopolysaccharide (LPS). MPLA improves immune response during bacterial sepsis infection.
Structure of 1699735-80-2
Ordering Information
*For research and manufacturing use only. We do not sell to patients.
Fast-Track Access to Precise Molecular Weight Products
Professional Solutions for Molecular Research
cGMP Capacity
- cGMP-grade lipid manufacturing
- Scalable from milligrams to kilograms
- 20+ years expertise in lipid chemistry
- In-stock supply in the US and Europe
- Comprehensive QC testing with COA, MSD
- High-purity synthetic and natural lipids
- Covers phospholipids, sterols, and sphingolipids
- 100+ types of custom lipid modifications
- Specialized lipids for LNP delivery
- Functionalized and fluorescently labeled lipids
Popular Publications Citing BOC Sciences Products
- Specification
| Synonyms | Monophosphoryl Tri-acyl Lipid A |
| IUPACName | azanium;[(3S,5S,6R)-4-hydroxy-2-(hydroxymethyl)-5-[[(3R)-3-tetradecanoyloxytetradecanoyl]amino]-6-[[(3S,5S,6S)-3,4,6-trihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]oxan-2-yl]methoxy]oxan-3-yl] hydrogen phosphate |
| CanonicalSMILES | CCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCC)CC(=O)NC1C(C(C(OC1OCC2C(C(C(C(O2)O)NC(=O)CC(CCCCCCCCCCC)O)O)O)CO)OP(=O)(O)[O-])O.[NH4+] |
| InChI | InChI=1S/C54H103N2O17P.H3N/c1-4-7-10-13-16-19-20-23-26-29-32-35-46(61)70-41(34-31-28-25-22-18-15-12-9-6-3)37-45(60)56-48-51(64)52(73-74(66,67)68)42(38-57)72-54(48)69-39-43-49(62)50(63)47(53(65)71-43)55-44(59)36-40(58)33-30-27-24-21-17-14-11-8-5-2;/h40-43,47-54,57-58,62-65H,4-39H2,1-3H3,(H,55,59)(H,56,60)(H2,66,67,68);1H3/t40-,41-,42?,43?,47+,48+,49-,50?,51?,52-,53+,54-;/m1./s1 |
| InChIKey | WBMOMCHVNLUEBA-UPPRWESDSA-N |
| Purity | >99% |
| ShelfLife | 1 Year |
| ExactMass | 1099.726 |
| Hygroscopic | No |
| LightSensitive | No |
| PercentComposition | C 58.94%, H 9.71%, N 3.82%, O 24.72%, P 2.81% |
Related Products
Contact our experts today for pricing and comprehensive details on our PEG offerings.
Planning to purchase or looking for custom solutions?
Get in touch with our experts today! We'll respond within 24 hours to discuss your project needs and provide a customized quote.
You May Also Be Interested In
From custom lipid synthesis to lipid nanoparticle formulation, discover complementary services tailored to your research needs.
Gain Deeper Insights
Browse related content to gain a deeper understanding of lipid synthesis and manufacturing.
PEG and PEG Derivatives
-

Polymers & Polymerizable Lipids
Nanocarriers, Surface Coating
-

Chirality Studies, Receptor Binding
-

Transfection, RNA Delivery
-

Gene Delivery, Nanoparticles
-

Bioconjugation, Imaging
-

Nutrition, Membrane Models
-

Biotech Applications, Functional Materials
-

Metabolism, Labeling
-

NMR, EPR Analysis
-

Drug Delivery, Nanocarriers
Online Inquiry